COPD Trial, Recruiting NCT05008081 Sponsor: Wim Janssens Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT05008081
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been diagnosed with COPD (a lung condition) by a doctor, either based on their medical history or a breathing test result
  • People who are currently in hospital with a suspected flare-up (sudden worsening) of their COPD
  • People who are enrolled in the trial within 48 hours of being admitted to hospital
  • People who have given written consent to take part voluntarily, or whose representative has done so on their behalf

Who may not be able to join:

  • People who are unwilling or unable to follow the study procedures
  • People whose COPD flare-up does not require treatment with steroid tablets, antibiotics, or both as a minimum level of care
  • People who have tested positive for COVID-19, or who are strongly suspected of having COVID-19 based on a doctor's examination

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wim Janssens, MD, PhD, UZ/KU Leuven - Belgium

Phone: 016342284

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wim Janssens
Registry
ClinicalTrials.gov
Start date
25 October 2022
Est. completion
1 March 2027

Where this trial is recruiting

🇦🇹 Austria 🇧🇪 Belgium 🇫🇷 France 🇩🇪 Germany 🇮🇹 Italy 🇳🇱 Netherlands 🇸🇮 Slovenia 🇪🇸 Spain 🇸🇪 Sweden Turkey (Türkiye) 🇬🇧 United Kingdom

Primary endpoints

All-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov